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The  role  of interferon  in  host  resistance  to  viral  infection  has  not  been 
established. Although administration  of interferon can confer a marked protec- 
tion on virus-infected animals  (1), the evidence that it is important in limiting 
virus infection has been indirect,  based for the most part on temporal associa- 
tions between the presence of virus and interferon in different tissues (2). Two 
direct means of determining  the role of interferon  in experimental  or natural 
virus infections would be: (a) use of an animal incapable of producing interferon 
or insensitive to its action (such an animal has not been described); and (b) use 
of a  selective inhibitor of interferon production or action.  Metabolic inhibiters 
which  inhibit  both  interferon  production  and  action  also  affect  many  host 
functions  and  are therefore  not selective.  An  anti-interferon  antibody should 
however combine selectively with  extracellular  interferon  produced by viral- 
infected tissues and prevent interferon from protecting uninfected cells. Faucon- 
nier has in fact shown that inoculation of sheep anti-mouse interferon serum of 
low potency was associated with a more rapid onset of disease and an increased 
mortality in mice infected with very small amounts of Semliki Forest virus (3, 
4).  The  development of techniques  for the  production  of potent and  partially 
purified mouse interferon  (5) enabled us to obtain sheep anti-mouse interferon 
serum 1,000-fold more potent than that previously used. Administration of this 
serum to mice markedly altered the evolution of several virus diseases, clearly 
demonstrating the importance of interferon in the early response to some viral 
infections.  We present in some detail  in this  article the results of our experi- 
ments using encephalomyocarditis virus and in the accompanying article the 
results of experiments using several other viruses. 
Materials  and Methods 
Virus.  The origin,  methods of preparation,  and  assay of the encephalomyocarditis  (EMC) 1 
virus used in these experiments have been previously described (6). Mice were injected intraperi- 
toneally (i.p.) or subcutaneously  (s.c.) with 0.2 ml of the given viral dilution. 
* Supported in part by grants from the D~l~gation Minist~rielle pour l'Armement, Direction des 
Recherches et Moyens d'Essais, contract no. 75/141, and the Foundation Simone et Cino Del Duca. 
Abbreviations used in this paper: EMC, encephalomyocarditis; HA, hemagglutination; NDV, 
Newcastle disease virus; PBS, phosphate-buffered saline; poly-I. C, polyriboinosinic-polycytidylic; 
TCIDso,  mean tissue culture infective dose; VSV, vesicular stomatitis virus. 
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Mice.  Swiss and C3H mice from pathogen-free colonies at the Institut du Cancer were used in 
these experiments. 
Preparation of Mouse Interferon.  Mouse interferon was prepared from suspension cultures of 
Swiss mouse C-243 cells (5) induced with Newcastle disease virus (NDV) and was concentrated, 
semipurified, and assayed as previously described (5). The sp act of  the mouse C-243 cell interferon 
preparations ranged between 2.8 ×  10  e and 1.2 × 107 reference units/mg protein. One of our mouse 
interferon units as quoted in the text equals four mouse interferon reference units. 
Immunization Procedures.  Sheep no. 1 was immunized by subcutaneous injection with 1 ml of 
mouse interferon preparations titering 1.6 x  10  -5 to 8  x  10 -5. It received a total of 24 injections in 
the course of 13 too, at which time the serum anti-interferon-neutralizing  titer was 6.4  ×  10 -3. 
Following techniques described by Mogensen et al. (7), the sheep was then injected twice s.c. with 
8  ×  10  e units of mouse interferon admixed with Freund's complete adjuvant.  This procedure 
increased the serum-neutralizing titer to 2.4  ×  10 -9. 
Sheep no. 4 received eight injections of mouse interferon of comparable titer over a period of 3 
mo, at which time the serum anti-interferon-neutralizing  titer was 2.5  x  10  -1 . The serum of this 
sheep served as one of the control sera (see Fig.  1 B). As a  further control, the serum globulin 
fraction  of sheep  (Iivar)  immunized  with  human  leukocyte  interferon  (7)  was  used,  kindly 
provided by Dr. E. Mogensen. 
Partial Purification of Antisera.  For the majority of experiments anti-interferon and control 
sera were processed as follows: Ca) 50 ml of each heat-inactivated (56°C for 30 rain) serum were 
absorbed three times with a total of 9 x  109 C-243 cells. Serum-ceU mixtures were incubated with 
agitation for 30 rain at 37°C and 30 rain at 4°C.  (b) Sera were then adsorbed on a  suspension of 
Swiss mouse spleen and thymic cells (6  ×  109 cells for 50 ml of serum), for 30 min at 37°C and 30 
min at 4°C. (c) Sera were centrifuged to eliminate cells and then ultracentrifuged at 100,000g for 1 
h. (d) The globulin fractions were precipitated with ammonium sulfate (39% saturation) and the 
protein content was determined by the  Lowry method  (8)  using bovine serum albumin  as  a 
standard. The protein content of  the globulin fractions prepared from the sera of sheep no. 1 was 44 
mg/ml; of sheep no. 4, 62.5  mg/ml; and of a normal sheep, 32 mg/ml. 
The degree of  purification of the globulin fraction of  the serum of sheep no. I was determined  by 
passive hemagglutination (HA) on tanned sheep erythrocytes according to the method of Boyden 
(9). The HA titers of crude antiserum (before absorption) and of the corresponding serum globulin 
(after absorption) were, respectively, 1:163,840 and 1:10,240 against an extract of C-243 cells; 1:160 
and  <1:5  against NDV-infected allantoic fluid; and 1:81,920  and  <1:5  against calf serum. The 
crude sheep anti-interferon  serum (before absorption) had a cytotexic titer of 1:80 for C-243 cells (in 
the presence of rabbit complement), whereas the globulin fraction (after absorption) exerted no 
toxicity at a dilution of 1:10. 
No appreciable loss of anti-interferon antibody was observed after absorption and precipitation 
of the globulin fraction. Neither the crude serum nor the serum globulin from a  normal sheep 
contained antibodies to the above substances. 
Assay of Sera for Anti-Interferon-Neutralizing Antibody.  Serial twofold dilutions of serum 
were incubated for 1 h at 37°C and 2 h at 4°C with 8 units of mouse C-243 cell interferon. Mixtures 
were then incubated with monolayer cultures of  L cells for 18 h before challenge with approximately 
100 mean tissue culture infective doses (TCID59) of  vesicular stomatitis  virus (VSV). In each instance 
a simultaneous titration of the interferon used was included in the test. The neutralizing titer was 
taken as the highest dilution of antibody that inhibited by 50% the protective activity of at least 8 
units of interferon. The anti-mouse interferon titer of serum globulin from sheep no. 1 was 1.2  × 
10 -9 and from sheep no. 4, 2.5  ×  10  -l. The anti-human interferon titer of serum globulin from sheep 
Iivar was 3 × 10 -5 [assayed as previously described (7)] and its anti-mouse interferon titer was 10  -~ . 
Experimental Plan.  Unless otherwise indicated 1-mo-old male  or female Swiss mice were 
inoculated in the tail vein with 0.1 ml (44 mg protein/ml) of serum globulin from sheep no. 1 or 0.14 
ml (34 mg protein/ml) of serum globulin from a normal sheep, and then immediately inoculated 
i.p. or s.c. with the virus suspension. Mice were observed for at least 2 wk. 
Determination of EMC Virus Content in Tissues of Mice.  Mice were first exsanguinated and 
the heart, liver, spleen, kidney, and brain removed individually. A  10% wt/vol homogenate in 
phosphate-buffered saline (PBS) was made for each organ [except for the liver (33% wt/vol)] and 
then centrifuged at 500 g  for 15 rain. The virus content of the supernate was titered in monolayer 
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Determination of  Interferon  Content in Tissues of Mice.  The same tissue homogenates assayed 
for EMC virus content were assayed for interferon after ultracentrifugation at 100,000 g  for 1 h. 
The superuate was then processed as follows: One part was dialyzed at pH 2 for 2 days to inactivate 
residual EMC virus. Another part was not subjected to pH 2 but was incubated with a 1:50 or 1:250 
dilution  of mouse  anti-EMC  virus  serum  (titer  1:40,000  against  103  TCIDso  of  EMC  virus). 
Interferon was assayed on monolayer cultures of mouse L cells challenged with VSV (5). 
Results 
Inoculation of 0.1 ml of a crude sheep anti-mouse interferon serum titering 1.2 
x  10  -s  or  the  globulin  fraction  of this  serum  (see  Materials  and  Methods) 
markedly  altered  the  response  of 1-mo-old  Swiss  mice  to  i.p.  infection  with 
approximately  100  LDso of EMC  virus.  Control  virus-infected  mice  appeared 
healthy until the 4th day, when they developed neurologic signs of disease. 25- 
50% of these mice died with signs of encephalitis on the 4th day and 50-75% were 
dead  by  the  5th  day.  In  contrast,  mice  treated  with  anti-interferon  serum 
appeared severely ill 24-36 h after viral infection. They remained almost immo- 
bile although  neurologic  signs of disease were not apparent.  In  most experi- 
ments virtually all of these mice were dead by the 2nd day. 
Effect of Varying Amounts of Anti-Mouse Interferon Globulin on Infection of 
Mice with EMC Virus.  Mice were infected i.p. with approximately 100 LDso of 
EMC virus and then injected with 10-fold dilutions of anti-interferon  globulin. 
Undiluted anti-interferon globulin (titer 1.2  x  10  -e) exerted a marked effect on 
EMC  infection  in  mice  (Fig.  1 A).  A  significant  but  less  marked  effect was 
observed in mice injected with anti-interferon  globulin titering  1.2  x  10  -5 and 
1.2  x  10  -4 but virtually no effect was observed in mice injected with globulin 
titering 1.2 × 10  -3 (Fig. 1 A). In all the following experiments mice were injected 
intravenously (i.v.) with 0.1 ml of the anti-interferon globulin (or normal sheep 
globulin) diluted 1:3 in PBS to give an anti-interferon  titer of 4  ×  10  -5. 
Effect of Different  Sheep  Globulin  Preparations  on Infection  of Mice  with 
EMC Virus.  To determine the specificity of the effect of the sheep anti-mouse 
interferon globulin on EMC virus infection, mice were infected i.p. with approx- 
imately 100 LDso of virus and then injected i.v. with 0.1 ml of either sheep anti- 
mouse interferon globulin (sheep no. 1) (titer of 4  ×  10-5); normal sheep serum 
globulin; the serum globulin of the incompletely immunized sheep (no. 4); or the 
serum globulin from sheep (Iivar) immunized with human leukocyte interferon. 
Only  mice  injected  with  potent  anti-mouse  interferon  globulin  showed  the 
accelerated response to EMC virus infection (Fig.  1 B). 
Clearance and Absence of Toxicity of Sheep Anti-Mouse Interferon Globulin 
in Swiss Mice.  1-mo-old Swiss mice were injected i.v. with anti-mouse inter- 
feron globulin (titer, 4  ×  10  -~) and sacrificed in the ensuing days. As can be seen 
in  Fig.  2,  significant  anti-mouse  interferon-neutralizing  titers  were  still  de- 
tected in the serum at 25 days. 
Crude anti-interferon serum or anti-interferon globulin exerted no discernible 
effects on uninfected mice kept for several months.  Furthermore,  splenic lym- 
phocytes harvested 48 h after inoculation of sheep anti-mouse interferon globu- 
lin were as sensitive to phytohemagglutinin  stimulation of tritiated thymidine 
incorporation as splenic lymphocytes from control mice. 
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FIG.  1.  (A). Effect of varying dilutions of sheep anti-mouse interferon globulin on EMC 
virus infection (100 LDso i.p.) in 1-mo-old Swiss mice. Mice were injected i.v. with 0.1 ml of 
anti-mouse interferon globulin titering 1.2 ×  10  -e, (Q); 1.2 x  10 -5, (b); 1.2 x  10  -4, (T); 1.2 x 
10  -~,  (.); normal sheep serum globulin, (O); or left untreated,  (X). There were eight mice 
per group.  (B) Effect of different sheep globulin fractions on EMC virus infection (100 LD5o 
i.p.)  in 1-mo-old Swiss mice.  Mice were injected i.v.  with 0.1 ml of serum globulin from 
sheep no. 1 (anti-mouse interferon titer, 4 x  10-5), (Q); from sheep no. 4, ([]); from a normal 
sheep, (O); and from sheep Iivar (anti-human leukocyte interferon), (<>); or left untreated, 
(X). There were 15 mice per group. 
Virus Inoculated i.p. or s.c.  Eight experiments were undertaken to determine 
the effect of sheep anti-mouse interferon globulin on the evolution of EMC virus 
infection. Injection of anti-interferon globulin resulted in an earlier onset of 
disease, and at lower dilutions of virus an increased mortality (Fig. 3). This was 
especially marked when EMC virus was injected subcutaneously (Exp. II, Fig. 
3), (the EMC virus titer was 10  -e-5 LD5o/0.2 ml for control mice and 10  -8.4 LDso/ 
0.2 ml for mice injected with anti-interferon globulin). Although most experi- 
ments were undertaken with Swiss mice, comparable results were also obtained 
in one experiment with C3H mice. 
EMC  Virus  Content  in  Tissues  of Mice  Injected  with  Sheep  Anti-Mouse 
Interferon Globulin.  In view of the overwhelming course of EMC virus infec- 
tion in mice injected with anti-interferon globulin, it was of interest to deter- 
mine the amount of EMC virus in the different organs. Accordingly, 1-mo-old 
Swiss mice were infected with EMC virus and then inoculated i.v. with either 
anti-interferon globulin or normal sheep globulin. Four mice from each group 
were sacrificed every 12 h. 
EMC virus was found earlier and in considerably greater titer in the serum, 
spleen,  liver,  kidney, and  heart of mice treated with anti-mouse interferon 
globulin than in mice treated with normal sheep globulin (Fig. 4). Of particular 
interest was the finding that as early as 24 h after viral inoculation the titers of 
EMC virus in the livers of two anti-interferon-treated mice were 10  -5.7 and 10  -6.5 GRESSER,  TOVEY~ BANDU,  MAURY,  AND  BROUTY-BOY]~  1309 
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FIG.  2.  Mice were injected i.v. with 0.1 ml of sheep anti-interferon globulin (anti-inter- 
feron titer, 4 x  10 -~) and at various times thereafter the serum anti-interferon-neutralizing 
titer was determined on individual mice (0). (No anti-mouse interferon-neutralizing  activ- 
ity was present in a  1:10 dilution of uninoculated mice.) 
TCIDso/0.2 ml of homogenate and at 36 h the virus titers in the livers of all four 
mice were greater than 10  -5.3 TCIDso/0.2 ml. In contrast, EMC virus multiplica- 
tion was minimal or not detected at this time in the livers of mice treated with 
normal  sheep  serum  globulin.  In  view  of the  clinical  course  of disease  in 
antiserum-treated mice referred to above, it was of interest that at the time of 
death (36-48 h) the EMC virus titers in the brain were considerably below those 
found in control mice dying of EMC virus encephalitis (see values for the brains 
of control mice at 96 h) (Fig. 4). 
Presence of Interferon  in Tissues  of Virus-Infected  Mice Injected with Anti- 
Mouse Interferon  Globulin.  The same tissue homogenates assayed for EMC 
virus content were also assayed for the presence of interferon (with the excep- 
tion of serum). 
MICE INJECTED WITH NORMAL SHEEP GLOBULIN.  Interferon was detected only 
in the brains of mice injected with normal sheep globulin. Titers of 1:60 to 1:160 
were present in homogenates of brain in 2/4 mice at 72 h and in 2/3 mice at 96 h. 
Significant levels of interferon (>1:20) were not detected in any of the homoge- 
nates of liver, spleen, kidney, or heart from EMC virus-infected mice harvested 
between 12 and 96 h. (All specimens were assayed before and after treatment at 
pH 2, see Materials and Methods.) 
MICE INJECTED WITH ANTI-INTERFERON GLOBULIN.  When liver homogenates 
were assayed for interferon before treatment at pH 2 (but after ultracentrifuga- Virus  injected  i.p. 
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FIG.  3.  1-mo-old Swiss  mice  were  injected i.v.  with  0.1  ml  of anti-interferon  globulin 
(titer, 4  x  10-5),  (O); or with normal serum globulin,  (O); or left untreated,  (X). All mice 
were inoculated i.p. or s.c. with 0.2 ml of viral dilutions as indicated. There were eight and 
six mice per treatment group for each virus dilution in experiments I and II, respectively. 
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Fro.  4.  EMC virus content  in tissues of mice  injected  i.v.  with 0.1  ml of anti-interferon 
globulin,  (0) (titer, 4  ×  10-5); or normal sheep globulin,  (©). All mice were inoculated i.p. 
with approximately  100 LD~o of EMC virus. 
tion of the homogenate and addition of mouse anti-EMC virus serum) interferon. 
was either not detected or the titers were low (open squares,  Fig. 5).  However 
when these same liver homogenates were assayed after treatment at pH 2, high 
levels of interferon were detected  (closed squares,  Fig.  5).  Interferon was also 
present in the homogenates of kidney, heart, and spleen but there appeared to 
be little difference in titer between pre- and post-pH 2-treated samples. 
The amount of interferon in a given organ (after passage of the sample at pH 
2) was related to the virus titer. For example, at 24 h the EMC virus titers of the 
liver homogenates of two mice were 10 -6.5 and 10 -5.7 and the interferon titers 
were 1:650 and 1:80, respectively,  whereas the virus titers in the livers of two 
other mice at this time were 10 -3.5 and <10 -2 and no interferon was detected in 
these homogenates. 2 
The relationship between the virus titer in the liver, kidney, heart, or spleen 
of virus-infected  mice  treated  with  anti-mouse  interferon  globulin  and  the 
corresponding interferon titer (post-pH 2 treatment) in the homogenate is shown 
in Fig. 6.  Interferon was only detected when the virus titer was 104 TCIDs0/0.2 
ml of homogenate or greater. 
Lack of Toxicity for Mice of Mixtures of Mouse Interferon and Anti-Interferon 
2 Furthermore  it was of interest that anti-interferon-neutralizing  activity was present in pre- 
pH  2  homogenates  of  liver  of these  latter  two  mice,  but  could  not  be  detected  in  the  liver 
homogenates containing significant levels of interferon (two mice at 24 h, four mice at 36 h, and 1 
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Fro. 5.  Interferon  content in tissues  of  mice inoculated with EMC  virus and treated with 
anti-mouse interferon  globulin.  [], specimen tested  before  treatment at pH 2; I, specimen 
tested  after  treatment at pH 2. 
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Globulin.  Although  the  rapid  onset of extensive viral  multiplication  in the 
organs  of anti-interferon  globulin-treated  mice  appeared  responsible  for  the 
overwhelming evolution of disease and early death, it was considered of interest 
to determine whether interferon-anti-interferon  serum complexes might exert 
any ill effects. Two types of experiments were undertaken: 
(a)  To induce  the  production  of endogenous  interferon,  mice  were injected 
with NDV in four experiments or with polyriboinosinic-polycytidylic acid (poly- 
I. C) in six experiments.  Some mice were immediately inoculated with normal 
sheep globulin or PBS, and others were inoculated with anti-interferon globulin. 
Interferon  was  only  detected  in  the  serum  of mice  injected  with  interferon 
inducer and normal globulin or PBS (1:4,000 to 1:24,000 units for NDV and 1:640 
to hl,280 units for poly I. C inoculated mice), and not in the serum  (<1:50) of 
mice injected with inducer and anti-interferon globulin. No ill effects were noted 
in any of the mice over a prolonged observation period. 
(b) 10-fold dilutions of mouse interferon were incubated with a large amount 
of anti-interferon globulin and 10-fold dilutions of anti-interferon globulin were 
incubated with a  large amount of interferon.  Each mixture  was injected into 
three mice. No ill effects were noted in any of the mice during a 1 mo observation 
period. 
Discussion 
Mice infected  either s.c.  or i.p.  with I00 LDso of  EMC  virus die with signs of 
central nervous system (CNS) disease towards the 4th to 5th day. In contrast, 
the course of the disease was entirely  different  in EMC  virus-infected mice 
inoculated with a potent sheep anti-mouse interferon  globulin.  Signs of  disease 
were apparent in these mice as early as 24 h. At 36 h all mice were moribund 
without any obvious signs of  CNS disease and at  48 h almost all  mice had died. 
This rapid evolution of  disease was never seen in untreated mice, nor in mice 
treated with the serum globulin from a normal sheep, nor from a sheep exhibit- 
ing a low anti-mouse interferon-neutralizing  titer,  nor from a sheep having a 
high titer  of  antibody to human leukocyte interferon (Fig. 1  B). 
In control infected mice, EMC  virus was either  not detected or was present 
only in low titers  in the serum and visceral  organs, but attained high titers  in 
the brain towards the 4th to  5th  day at  which time mice died with an encephali- 
tis.  In  contrast,  in  mice treated with anti-mouse interferon  globulin,  EMC  virus 
multiplied to  high titer  in several visceral  organs (i.e.,  heart, liver,  spleen, and 
kidney) 24-36 h after  viral  inoculation (Fig.  4).  These mice appeared to  die  of  an 
overwhelming systemic infection  before virus had multiplied to  high titer  in  the 
brain. 
We infer  therefore  from the  use of  anti-interferon  serum that  the  production of 
interferon in visceral organs is an important early event that inhibits viral 
multiplication in these organs.  3 Thus, in the anti-interferon  globulin-treated 
mice, virus multiplies in  the visceral  organs and interferon  is  produced but can 
not  protect  neighboring cells  because of  the ubiquitous presence of  high levels  of 
Although we were unable to demonstrate interferon  in liver,  spleen, kidney, and heart 
homogenates of  control  mice in the experiment reported herein, we have been able in previous 
experiments  with  EMC virus  to  demonstrate  its  presence  in  very  small  amounts  in  these  organs. 1314  INTERFERON  IN  VIRUS  INFECTIONS  IN  MICE.  I 
anti-interferon globulin (Fig. 2). Virus multiplication ensues unchecked, attain- 
ing  very  high  titers  especially  in  the  liver  (in  control  mice  only  minimal 
amounts of virus can be recovered from the liver). 
It was of interest to note that interferon was either not detected or detected in 
only small amounts in crude homogenates of livers from anti-interferon  globu- 
lin-treated mice.  However, when these same homogenates were assayed after 
treatment at pH 2 it was apparent that relatively high levels of interferon were 
in  fact present.  Presumably  prolonged  treatment  at  pH  2  dissociated  or  de- 
stroyed the antibody-interferon  complex, thus permitting  the detection of the 
interferon present. Thus, anti-interferon globulin did not block the synthesis of 
interferon by viral-infected cells but rather neutralized  its activity extracellu- 
larly. 4 (We have at present no explanation  for the finding that no significant 
difference was observed in the interferon titers of pre- and post-pH 2 treatment 
of homogenates of other organs.) 
Although  it  may  seem  a  paradox  that  interferon  was  found  in  the  organ 
homogenates of mice treated with anti-interferon  globulin,  (and not in control 
virus-infected mice except in the brains), this may be explained by the extent of 
viral multiplication  in these organs.  It has been reported that the amount of 
interferon  in  a  given  tissue  is  often  directly  related  to  the  extent  of viral 
multiplication  (10), and our experimental results clearly support these observa- 
tions (Fig. 6). Fauconnier also observed that the amount of serum interferon was 
greater in Semliki Forest virus-infected mice treated with anti-interferon serum 
than in control mice (4). 
It is important  to emphasize that neither the crude sheep anti-mouse inter- 
feron serum nor the globulin fraction prepared after absorption of this serum on 
known  contaminants  (of the  interferon  preparations  used  to  immunize  the 
sheep) exerted any ill effects in mice kept for extended periods of time. Further- 
more, all our results indicate that the anti-mouse interferon serum acts in vivo 
by neutralizing  interferon.  We have no evidence that complexes of interferon- 
anti-interferon  antibody  contribute  in  any  way  to  the  fulminating  disease 
observed.  Thus  mixture  in  different  proportions  of interferon  and  antibody 
exerted no discernible effect on mice.  Likewise, large amounts of endogenous 
interferon were induced in NDV- or poly-I. C-inoculated mice and no ill effects 
were observed when this interferon was neutralized in vivo by injection of anti- 
interferon globulin. We conclude therefore that the sheep anti-interferon globu- 
lin  used  acts  selectively to  neutralize  extracellular  interferon,  and  that  the 
overwhelming disease in these EMC virus-infected mice attests to the impor- 
tance of interferon in limiting viral multiplication and delaying the evolution of 
this experimental viral disease. 
Summary 
The  role  of interferon  in  the  pathogenesis  of encephalomyocarditis  (EMC) 
virus infection was determined by treating mice with potent, partially purified 
4 The  efficacy  of our  anti-interferon serum  in  neutralizing  large  amounts  of endogenous 
interferon was further emphasized by the apparent absence of significant levels of interferon in 
the serum of anti-interferon globulin-treated mice injected with NDV or poly-I. C in contrast to the 
high levels of serum interferon found in control mice inoculated with these inducers. GRESSER,  TOVEY,  BANDU,  MAURY,  AND  BROUTY-BOYE  1315 
sheep anti-mouse interferon globulin. In control mice, EMC virus was present in 
low titers in various visceral organs but attained high titers in the brain towards 
the 4th to 5th day, at which time mice died with signs of central nervous system 
disease. In mice treated with anti-mouse interferon globulin, virus was present 
in high titer in visceral organs 24-36 h  after viral inoculation and virtually all 
mice were dead by 48 h. This rapid evolution of EMC virus infection was not 
observed in  mice treated with the globulin fraction prepared from a  normal 
sheep, from a  sheep exhibiting a  low anti-mouse interferon-neutralizing titer, 
nor from a sheep having a high titer of antibody to human leukocyte interferon. 
The experimental results indicated that anti-interferon globulin neutralized the 
interferon liberated  by  virus-infected cells,  thus  permitting  extensive  virus 
multiplication in  several visceral  organs.  We  conclude that  interferon is  an 
important early component of host resistance to this virus infection. 
We are deeply indebted to Miss D.  Buffe and  Miss C.  Rimbaud for their constant advice and 
encouragement in the preparation of the sheep anti-mouse interferon serum, and for the technical 
assistance of Mrs.  J. Buywid and Miss J. Begon-Lours. 
Received for publication 8 July 1976. 
References 
1.  Finter, N. B. 1973. Interferons and inducers in vivo. I. Antiviral effects in experimen- 
tal animals. Front. of Biol. 2"135. 
2.  Baron, S.  1973. The defensive and biological roles of the interferon system. Front. 
Biol.  2"267. 
3.  Fauconnier,  B.  1970. Augmentation  de  la  pathog~nicit~  virale  par  l'emploi  de 
s~rum anti-interferon in vivo. C. R. Hebd. Seances Acad. Sci. 271"1464. 
4.  Fauconnier,  B.  1971. Effet du  s~rum  anti-interferon sur  la  pathog~nicite  virale 
exp~rimentale "in vivo". Pathol. Biol.  19-575. 
5.  Tovey, M.  G.,  J.  Begon-Lours,  and I.  Gresser.  1974. A method for the large scale 
production of potent interferon preparations. Proc. Soc. Exp. Biol. Med.  146"809. 
6.  Gresser,  I.,  C.  Bourali,  M.  T.  Thomas,  and  E.  Falcoff.  1968. Effect of repeated 
inoculation of  interferon preparations on infection of  mice with encephalomyocarditis 
virus. Proc. Soc. Exp. Biol. Med.  127"491. 
7.  Mogensen,  K.  E.,  L.  Pyh~il~i, and K.  Cantell.  1975. Raising antibodies to human 
leukocyte interferon. Acta Pathol.  Microbiol. Scand. Sect. B  Microbiol. Immunol. 
83:443. 
8.  Lowry, O.  H.,  N.  J.  Rosebrough,  A.  L.  Farr,  and  R.  J.  Randall.  1951. Protein 
measurement with the folin phenol reagent. J. Biol. Chem.  193:265. 
9.  Boyden, S. V.  1959. Approaches  to the problem  of detecting antibodies.  In  Mecha- 
nisms of Hypersensitivity. J. H. Shaffer, G. A. Lo Grippo, and M. W. Chase, editors. 
Churchill (J.&A.) Ltd., London. 
10.  Vil~ek, J. 1960. Interferon. Virol. Monogr. 6:1. 